No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 1, 2006, Pages 175-177

  Millikan, Robert C ^a   Heard, Kimberley ^a   Winkel, Scott ^a   Hill, Edgar J ^a   Heard, Kristin ^a   Massa, Beri ^a   Mayes, Lydia ^a   Williams, Patricia ^a   Holston, Rachel ^a   Conway, Kathleen ^a   Edmiston, Sharon ^a   De Cotret, Allan René ^a  

^a IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

AFRICAN AMERICAN; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; EUROPEAN AMERICAN; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; PROMOTER REGION; ALLELE; BREAST TUMOR; CASE CONTROL STUDY; CAUCASIAN; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; MUTATION; RISK; TUMOR SUPPRESSOR GENE; UNITED STATES;

AFRICAN AMERICANS; AGE OF ONSET; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MUTATION; NORTH CAROLINA; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MDM2;

EID: 33645459643     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0692     Document Type: Article

References (10)

1. Freedman D, Levine A. Regulation of the P53 protein by the MDM2 oncoprotein-38th G.H.A. Clowes Memorial Award Lecture. Cancer Res 1999;59:1-7.
2. Bond G, Hu W, Bond E, et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the P53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 2004;119:591-602.
3. Newman B, Moorman PG, Millikan R, et al. The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 1995;35:51-60.
4. Hall I, Moorman P, Millikan R, Newman B. Comparative analysis of breast cancer risk factors among African-American women and white women. Am J Epidemiol 2005;161:40-51.
5. Millikan R, Eaton A, Worley K, et al. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. Breast Cancer Res Treat 2003;79:355-64.
6. Conway K, Edmiston S, Cui L, et al. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Res 2002;62:1987-95.
7. Furberg H, Millikan RC, Geradts J, et al. Environmental factors in relation to breast cancer characterized by p53 protein expression. Cancer Epidemiol Biomarkers Prev 2002;11:829-35.
8. Huang W-Y, Newman B, Millikan R, Schell M, Hulka B, Moorman P. Hormone-related factors and risk of breast cancer by estrogen receptor and progesterone receptor status. Am J Epidemiol 2000;151:703-14.
9. Schaid D, Jacobsen S. Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg equilibrium. Am J Epidemiol 1999;149:706-11.
10. Gibson G. Population genomics: finding the variants of mass disruption. Curr Biol 2003;13:R901-3.